Clinical Trials in Brussels, Brussels Capital
1 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 2Phase 3
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie840 enrolled61 locationsNCT06236438
Recruiting
Phase 2
Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)
Jules Bordet Institute112 enrolled1 locationNCT06150898
Recruiting
Not Applicable
Study of Lipid Mediators in Chronic Postoperative Pain - LICP
Breast Cancer FemalePostoperative Pain
Université Catholique de Louvain300 enrolled1 locationNCT06907810
Recruiting
Not Applicable
Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment
Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre160 enrolled1 locationNCT06828640